Pharmaceutical Cannabidiol production by Insys Therapeutics granted DEA Approval
Friday, October 17, 2014
Insys Therapeutics, Inc. has stated that its Food and Drug Administration (FDA) inspected and Drug Enforcement Agency (DEA) examined and approved facility in Round Rock, Texas, has got DEA approval to manufacture pharmaceutical grade Cannabidiol (CBD) synthetically.
The Company has also been allowed a quota to produce 15kg of CBD in 2014. Insys believes these quantities are sufficient to follow-up its CBD development program as planned.
Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve the quality of life of patients. Using our proprietary sublingual spray technology and our capability to develop pharmaceutical cannabinoids, Insys addresses the clinical shortcomings of existing commercial products.
